Hidrocloruro De Efedrina Altan

Hidrocloruro De Efedrina Altan is a prescription medication that contains ephedrine hydrochloride as its active ingredient. The product is supplied in an intravenous formulation, with the exact strength not disclosed in the available data. Marketed within the European Union, it belongs to the sympathomimetic amine class and is used under medical supervision for conditions that benefit from its bronchodilating, decongestant, and vasopressor therapeutic clinical properties.

Hidrocloruro De Efedrina Altan is indicated for several acute medical situations where stimulation of the sympathetic nervous system is required.

- Management of hypotension, especially during anesthesia or shock. - Relief of bronchospasm associated with asthma or chronic obstructive pulmonary disease. - Temporary reduction of nasal congestion caused by upper respiratory infections. - Adjunctive therapy to increase blood pressure in certain surgical procedures. - Central nervous system stimulant use under strict monitoring for selected diagnostic tests.

Adverse reactions to ephedrine hydrochloride may vary in frequency and severity.

Common: - Increased heart rate (tachycardia) - Elevated blood pressure - Nervousness or restlessness - Tremor - Headache - Insomnia

Serious: - Cardiac arrhythmias - Severe hypertension - Myocardial ischemia - Cerebral hemorrhage - Allergic reactions such as rash or anaphylaxis

When prescribing Hidrocloruro De Efedrina Altan, clinicians should consider several precautionary measures to minimize risk.

- Assess cardiovascular status before use, especially in patients with coronary artery disease. - Avoid in uncontrolled hypertension or hyperthyroidism. - Use cautiously in pregnant or breastfeeding individuals; data are limited. - Monitor for signs of central nervous system stimulation, such as agitation or seizures. - Adjust dose or discontinue if severe tachyarrhythmias develop. - Consider renal or hepatic impairment may affect drug elimination. - Ensure appropriate intravenous administration techniques to prevent extravasation.

Ephedrine hydrochloride can interact with other medications, altering its efficacy or safety profile.

Avoid: - Monoamine oxidase inhibitors (MAOIs) – risk of hypertensive crisis. - β‑blockers – may blunt cardiovascular response. - Tricyclic antidepressants – increased sympathomimetic effects.

Use with caution: - Other sympathomimetic agents (e.g., pseudoephedrine) – additive pressor effects. - Diuretics – may exacerbate electrolyte disturbances. - Anticoagulants – potential for increased blood pressure affecting bleeding risk.